Healthstream (HSTM) Cash & Current Investments (2010 - 2026)

Healthstream (HSTM) has reported Cash & Current Investments for 17 consecutive years, with $66.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 26.36% year-over-year to $66.7 million in Q2 2026; TTM through Jun 2026 was $66.7 million, a 26.36% decrease from a year earlier, with the FY2025 full-year figure at $57.0 million, down 41.36% from the prior year.
• Cash & Current Investments was $66.7 million for Q2 2026 at Healthstream, roughly flat from $66.5 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $113.3 million in Q1 2025 and troughed at $39.2 million in Q2 2022.
• A 5-year average of $71.9 million and a median of $68.9 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments jumped 48.31% in 2024 and tumbled 41.36% in 2025, its largest moves.
• Over 5 years, Cash & Current Investments stood at $53.9 million in 2022, then surged by 31.95% to $71.1 million in 2023, then surged by 36.67% to $97.2 million in 2024, then plunged by 41.36% to $57.0 million in 2025, then increased by 17.06% to $66.7 million in 2026.
• The last three Cash & Current Investments figures came in at $66.7 million (Q2 2026), $66.5 million (Q1 2026), and $57.0 million (Q4 2025), per Business Quant data.